September 12, 2017AnesthesiologyOpen Access

Malignant Hyperthermia in the Post-Genomics Era

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

SRSheila RiaziUniversity Health Network NKNatalia KraevaRutgers, The State University of New Jersey PHPhilip M. HopkinsAtkins (United States)

Discussion

Member takes

Implication

Genetic testing limitations for malignant hyperthermia warrant clinical caution; review extends RYR1 phenotype knowledge but leaves diagnostic standardization open.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Riazi et al. (2017) studied this question.

synapsesocial.com/papers/6a76820cb8e2d31284295a4d https://doi.org/10.1097/aln.0000000000001878

View Full Paper

Ask AI

Bookmark

Implication

Genetic testing limitations for malignant hyperthermia warrant clinical caution; review extends RYR1 phenotype knowledge but leaves diagnostic standardization open.

Malignant Hyperthermia in the Post-Genomics Era

Discussion

Member takes

Implication

Key Points

Cite This Study

Malignant Hyperthermia in the Post-Genomics Era

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider